izpis_h1_title_alt

The evolving role of microsampling in therapeutic drug monitoring of monoclonal antibodies in inflammatory diseases
ID Mingas, Panagiotis-Dimitrios (Avtor), ID Zdovc, Jurij (Avtor), ID Grabnar, Iztok (Avtor), ID Vovk, Tomaž (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (959,28 KB)
MD5: F2A67BF7B3E2B53EFEFD3887AC13A419
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/1420-3049/26/6/1787 Povezava se odpre v novem oknu

Izvleček
Monoclonal antibodies (mAbs) have been extensively developed over the past few years, for the treatment of various inflammatory diseases. They are large molecules characterized by complex pharmacokinetic and pharmacodynamic properties. Therapeutic drug monitoring (TDM) is routinely implemented in the therapy with mAbs, to monitor patients’ treatment response and to further guide dose adjustments. Serum has been the matrix of choice in the TDM of mAbs and its sampling requires the visit of the patients to laboratories that are not always easily accessible. Therefore, dried blood spots (DBS) and various microsampling techniques have been suggested as an alternative. DBS is a sampling technique in which capillary blood is deposited on a special filter paper. It is a relatively simple procedure, and the patients can perform the home-sampling. The convenience it offers has enabled its use in the quantification of small-molecule drugs, whilst in the recent years, studies aimed to develop microsampling methods that will facilitate the TDM of mAbs. Nevertheless, hematocrit still remains an obstacle that hinders a more widespread implementation of DBS in clinical practice. The introduction of novel analytical techniques and contemporary microsampling devices can be considered the steppingstone to the attempts made addressing this issue.

Jezik:Angleški jezik
Ključne besede:microsampling, DBS, VAMS, mAbs, TDM, inflammatory diseases
Vrsta gradiva:Članek v reviji
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2021
Št. strani:19 str.
Številčenje:Vol. 26, iss. 6, art. 1787
PID:20.500.12556/RUL-135187 Povezava se odpre v novem oknu
UDK:616-002:616.1/.9
ISSN pri članku:1420-3049
DOI:10.3390/molecules26061787 Povezava se odpre v novem oknu
COBISS.SI-ID:56889347 Povezava se odpre v novem oknu
Datum objave v RUL:28.02.2022
Število ogledov:591
Število prenosov:103
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Molecules
Skrajšan naslov:Molecules
Založnik:MDPI
ISSN:1420-3049
COBISS.SI-ID:18462981 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:22.03.2021

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:vnetje, bolezni

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P1-0189
Naslov:Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj